Vicenti I - Search Results

1

Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses.

Del Rosario García-Lozano M, Dragoni F, Gallego P, Mazzotta S, López-Gómez A, Boccuto A, Martínez-Cortés C, Rodríguez-Martínez A, Pérez-Sánchez H, Manuel Vega-Pérez J, Antonio Del Campo J, Vicenti I, Vega-Holm M, Iglesias-Guerra F. Del Rosario García-Lozano M, et al. Among authors: vicenti i. Bioorg Chem. 2023 Apr;133:106408. doi: 10.1016/j.bioorg.2023.106408. Epub 2023 Feb 4. Bioorg Chem. 2023. PMID: 36801791 Free article.

2

Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.

Corvasce S, Violin M, Romano L, Razzolini F, Vicenti I, Galli A, Duca P, Caramma I, Balotta C, Zazzi M. Corvasce S, et al. Among authors: vicenti i. Antivir Ther. 2006;11(3):329-34. Antivir Ther. 2006. PMID: 16759049

3

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

Bekele Y, Graham RL, Soeria-Atmadja S, Nasi A, Zazzi M, Vicenti I, Naver L, Nilsson A, Chiodi F. Bekele Y, et al. Among authors: vicenti i. Front Immunol. 2018 Jan 10;8:1966. doi: 10.3389/fimmu.2017.01966. eCollection 2017. Front Immunol. 2018. PMID: 29375579 Free PMC article.

4

Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection.

Vergori A, Rossetti B, Vicenti I, Meini G, Lentini G, Valoriani B, Caudai C, Morandi M, Cusi MG, Zazzi M, De Luca A. Vergori A, et al. Among authors: vicenti i. Infez Med. 2020 Nov 1;28(4):576-586. Infez Med. 2020. PMID: 33257634 Free article.

5

Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA.

Bavaro DF, Di Carlo D, Rossetti B, Bruzzone B, Vicenti I, Pontali E, Zoncada A, Lombardi F, Di Giambenedetto S, Borghi V, Pecorari M, Milini P, Meraviglia P, Monno L, Saracino A. Bavaro DF, et al. Among authors: vicenti i. Antivir Ther. 2020;25(2):61-71. doi: 10.3851/IMP3349. Antivir Ther. 2020. PMID: 32118584

6

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database.

Rossotti R, Borghi V, Callegaro AP, Micheli V, Bruzzone B, Colao G, Gismondo MR, Vicenti I, Penco G, Zazzi M, Rusconi S. Rossotti R, et al. Among authors: vicenti i. J Clin Virol. 2016 Oct;83:48-53. doi: 10.1016/j.jcv.2016.08.293. Epub 2016 Aug 23. J Clin Virol. 2016. PMID: 27591555

7

Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.

Alteri C, Scutari R, Bertoli A, Armenia D, Gori C, Fabbri G, Mastroianni CM, Cerva C, Cristaudo A, Vicenti I, Bruzzone B, Zazzi M, Andreoni M, Antinori A, Svicher V, Ceccherini-Silberstein F, Perno CF, Santoro MM. Alteri C, et al. Among authors: vicenti i. Virus Genes. 2019 Jun;55(3):290-297. doi: 10.1007/s11262-019-01649-z. Epub 2019 Feb 22. Virus Genes. 2019. PMID: 30796743

8

Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.

Saladini F, Giannini A, Boccuto A, Vicenti I, Zazzi M. Saladini F, et al. Among authors: vicenti i. J Clin Lab Anal. 2018 Jan;32(1):e22206. doi: 10.1002/jcla.22206. Epub 2017 Mar 17. J Clin Lab Anal. 2018. PMID: 28303602 Free PMC article.

9

The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro.

Saladini F, Giannini A, Boccuto A, Tiezzi D, Vicenti I, Zazzi M. Saladini F, et al. Among authors: vicenti i. AIDS. 2017 Oct 23;31(16):2307-2309. doi: 10.1097/QAD.0000000000001616. AIDS. 2017. PMID: 28832412

10

Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood.

Vicenti I, Meini G, Saladini F, Giannini A, Boccuto A, Schiaroli E, Zazzi M. Vicenti I, et al. Clin Chem Lab Med. 2018 Feb 23;56(3):e75-e77. doi: 10.1515/cclm-2017-0587. Clin Chem Lab Med. 2018. PMID: 28915108 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page